Labshake search
Citations for R&D Systems :
51 - 100 of 1448 citations for 7H Benzocyclohepten 7 one 2 amino 5 6 8 9 tetrahydro 9CI since 2019
Citations are collected from bioRxiv only, the total number of publications could be much larger.
-
bioRxiv - Cancer Biology 2022Quote: ... bioreactor media were either left untreated or supplemented with anti– Siglec-9 antibody (5 μg mL-1; clone 191240, #MAB1139-500, R&D systems, USA). On day 5 ...
-
bioRxiv - Pathology 2019Quote: Supernatants were tested for 6 analytes (TNFa, IL-6, IL-8, IL-10, IL-1b, IL-1a) on a custom Human magnetic Luminex plate (R&D systems LXSAHM ...
-
bioRxiv - Developmental Biology 2022Quote: Cells were dissociated with TrypLE on day 6 and 8 of CMEC and PMEC protocol and stained with VE-Cadherin PE-conjugated Antibody (R&D Systems). Then VEC+ cells were sorted using FACSAria III ...
-
bioRxiv - Neuroscience 2021Quote: ... offspring at postnatal day 3 to 6 received 7 intraperitoneal injections with either PBS (controls) or 75 ng of carrier free recombinant mouse interleukin-6 (rmIL6, R&D Systems, Minneapolis MN).
-
bioRxiv - Immunology 2022Quote: ... α-ULPB2/5/6 (mouse, clone 165903) and α-CCR4-APC (clone 205410) from R&D Systems. α-mouse IgG-APC from Southern Biotech ...
-
bioRxiv - Immunology 2023Quote: ... and 50 μg/ml L-Ascorbic Acid)) supplemented with Growth Factor Cocktail (5 ng/ml BMP4, 5 ng/ml bFGF, 10 ng/ml IL-6 (R&D systems, 206-IL), 10 ng/ml Flt3L (PeproTech ...
-
bioRxiv - Molecular Biology 2022Quote: ... dTAG-7 (R&D Systems), at the final concentration of 500 nM ...
-
bioRxiv - Immunology 2022Quote: Llamas were immunized intramuscularly once per week over six weeks with carrier free recombinant human IL-9 or mouse IL-9 (R&D Systems). Each llama (4 in total ...
-
bioRxiv - Molecular Biology 2023Quote: ... The concentrations of IL-6 and IL-8 were measured in triplicate with the DuoSet ELISA Development System (R&D Systems, Minneapolis, MN) according to the manufacturer’s instructions ...
-
bioRxiv - Cancer Biology 2021Quote: ... Galectin-9 primary antibody (R&D systems, AF-2045) was added to sections at 1 μg/mL dilution and incubated overnight at 4 °C ...
-
bioRxiv - Bioengineering 2021Quote: ... and FGF-9 (200 ng·ml-1, R&D Systems). By day 7 ...
-
bioRxiv - Immunology 2023Quote: ... Siglec-9 blocking antibody (Clone 191240, R&D Systems) was added at a final concentration of 10 µg/mL ...
-
bioRxiv - Immunology 2023Quote: ... Siglec-9 blocking antibody (Clone 191240, R&D Systems) was added at a final concentration of 10 µg/mL ...
-
bioRxiv - Neuroscience 2019Quote: ... and passaged every 4-6 day in the presence of 5 μM ROCK inhibitor (R&D Systems) until the 4th passage (P4) ...
-
bioRxiv - Microbiology 2023Quote: ... anti-IL-8/IL-8 (MAB208, R&D Systems, 1:100), anti-CD45 (2403794 ...
-
bioRxiv - Immunology 2022Quote: ... cells were washed at day 7 and cultured at 0.5.106 cells/ml with 50 U/ml IL-2 (R&D Systems), 250 U/ml IFN-α (R&D Systems) ...
-
bioRxiv - Neuroscience 2023Quote: ... After transfection neurons were washed twice with NBP and treated with 20 μM (2R)-amino-5-phosphonovaleric acid (AP5; R&D Systems, 0105/10), an NMDA receptor antagonist to prevent transfection-induced neuronal overexcitation ...
-
bioRxiv - Immunology 2021Quote: ... and 5 ng/ml IL-2 (carrier-free; Tocris R&D Systems) added with cells ...
-
bioRxiv - Microbiology 2024Quote: Interleukin-8 (IL-8) concentrations were determined with the IL-8/CXCL8 DuoSet ELISA kit (R&D Systems, Cat# DY208), CXCL12 with the CXCL12/SDF-1 DuoSet ELISA kit (R&D Systems ...
-
bioRxiv - Cell Biology 2019Quote: ... goat anti-Galectin-9 (AF2045, R&D systems, Minneapolis, Minnesota) at 1:1000 (v/v ...
-
bioRxiv - Immunology 2020Quote: ... MMP-9 Duoset ELISA was obtained from R&D Systems, Inc ...
-
bioRxiv - Immunology 2020Quote: ... the cells were cultured for 5 days in RP10 in the absence or presence of 10 ng/ml human IL-7 (R&D System). Cells were then stimulated for 6 hours with 0.5 μg/ml anti-CD49d clone L25 and 0.5 μg/ml anti-CD28 clone L293 (BD Biosciences) ...
-
bioRxiv - Immunology 2020Quote: ... 5×106 PBMCs were combined with 5×106 irradiated BLCLs from MHC-identical donor MCMs in 5 ml of RPMI-1640 containing 15% FCS (R15) and 10 ng/ml recombinant human IL-7 (R&D Systems). Cultures were supplemented 2 days later with 1.25 ml of R15 containing 100 U/ml recombinant human IL-2 (R&D systems ...
-
bioRxiv - Immunology 2022Quote: ... Monocyte differentiation into macrophages was performed for 5-7 days in the presence of human M-CSF (100 ng/ml) (R&D system). On the day of the assay ...
-
bioRxiv - Immunology 2020Quote: ... ELISA for IL-7 was performed using Mouse IL-7 Quantikine ELISA Kit M700 (R&D Systems) according to manufacturer’s instructions.
-
bioRxiv - Microbiology 2021Quote: ... and cultured in media containing IL-2 (5 ng/ml; R&D Systems), in the presence or in the absence of GGSK2691805A (5 μM) ...
-
bioRxiv - Immunology 2022Quote: ... PBMCs from healthy individuals were isolated and expanded in vitro for 7 days in the presence of 50 ng/ml of OKT-3 (Miltenyi) and 600 IU/ml IL-2 (R&D Systems) in AIM-V (Gibco ...
-
bioRxiv - Immunology 2022Quote: ... 5% CO2 for 8 days with 100 ng/ml macrophage colony-stimulating factor (M-CSF; R&D systems, cat.no 216-MC).
-
bioRxiv - Cell Biology 2022Quote: ... 5% CO2 for 8 days with 100 ng/ml macrophage colony-stimulating factor (M-CSF; R&D systems, cat.no 216-MC). Fully differentiated macrophages were harvested and seeded at the required density for the subsequent experiments.
-
bioRxiv - Cell Biology 2020Quote: ... [9] and 100ng/ml ActivinA (R&D Systems, 338-AC-050) for 3 days ...
-
bioRxiv - Cell Biology 2021Quote: ... 200 ng/mL FGF9 (fibroblast growth factor 9; R&D Systems), and 1 μg/mL heparin (Sigma-Aldrich)) ...
-
bioRxiv - Immunology 2021Quote: ... Antibodies included anti-MMP-9 (AF909; 1:100 R&D Systems); anti IL-1ß (ab9722 ...
-
bioRxiv - Bioengineering 2023Quote: ... 200 ng/ml fibroblast growth factor 9 (FGF9; R&D Systems), and 1 μg/ml heparin (Sigma-Aldrich ...
-
bioRxiv - Bioengineering 2023Quote: ... containing 9 ng/mL Activin A (R&D systems, #338-AC), 5 ng/mL BMP4 (R&D systems ...
-
bioRxiv - Bioengineering 2023Quote: ... IL-7 (5ng/ml; R&D Systems) and IL-15 (5ng/ml ...
-
bioRxiv - Microbiology 2022Quote: Interleukin-8 (IL-8) secretion was monitored by human CXCL8 ELISA (R&D Systems) as previously described(Shaffer et al. ...
-
bioRxiv - Developmental Biology 2019Quote: ... supplemented with 8 μM CHIR99021 and 4-8 ng/ml Noggin (R&D systems) for 2 days ...
-
bioRxiv - Cancer Biology 2023Quote: ... Levels of IL-8 were assessed using ELISA (R&D Systems (IL-8 #DY208). The data were normalized to cell number and reported as fold change of secreted protein compared to control.
-
bioRxiv - Cancer Biology 2020Quote: ... was confirmed by immunohistochemistry on FFPE tissues after antigen retrieval (pH 9) and endogenous peroxidase inhibition followed by overnight incubation with mouse antibody to SBase (anti-SBase; R&D Systems; pH 9; 1:200 dilution). After incubation with primary antibody ...
-
bioRxiv - Cancer Biology 2020Quote: ... was confirmed by immunohistochemistry on FFPE tissues after antigen retrieval (pH 9) and endogenous peroxidase inhibition followed by overnight incubation with mouse antibody to SBase (anti-SBase; R&D Systems; pH 9; 1:200 dilution), followed by incubation with primary antibody ...
-
bioRxiv - Microbiology 2021Quote: ... were cultured for 7 days in RPMI supplemented with 5% decomplemented autologous human blood plasma and 10 ng/mL M-CSF (R&D system, #216-MC) to obtain MDMs ...
-
bioRxiv - Immunology 2020Quote: ... and then brought to 1-2 million PBMCs/mL in R10 buffer plus 500pg/mL rhIL-7 (R&D Systems, Minneapolis, MN, USA) and rested again for four days ...
-
bioRxiv - Bioengineering 2023Quote: ... and further supplemented with 5 ng ml -1 of FGF-2 (R&D Systems). Medium was changed twice a week ...
-
bioRxiv - Cancer Biology 2023Quote: ... purified sheep IgG (2 mg/mL for LRIG1 R&D Systems #5-001-A), and mouse IgG1-PE conjugate (10 uL for LGR5 ...
-
bioRxiv - Bioengineering 2020Quote: ... supplemented with 1 ng/mL transforming growth factor beta-1 (TGF-β1) and 5 ng/mL fibroblast growth factor-2 (FGF-2) (both from R&D Systems) at 37°C and 5% CO2 in a humidified incubator (Thermo Scientific Heraeus ...
-
bioRxiv - Cell Biology 2021Quote: ... or MMP-9 at (1,10 & 100 ng/ml) (R&D Systems Europe) in protease buffer (50mM HEPES (pH 7.5 ...
-
bioRxiv - Immunology 2022Quote: ... or caspase-9 inhibitors (50 μM Z-LEHD-FMK, R&D Systems), respectively ...
-
bioRxiv - Immunology 2023Quote: ... moDCs were treated with recombinant galectin-9 protein (AF2045, R&D systems) at a final concentration of 1 µg/ml.
-
bioRxiv - Molecular Biology 2023Quote: ... 9 ng/ml Recombinant Human/Mouse/rat Activin A (R&D Systems) and 5 ng/ml human FGF-2 (Miltenyi Biotec) ...
-
bioRxiv - Bioengineering 2023Quote: ... Human mesenchymal stem cells (Passage 5-7) (commercially obtained from Rooster Bio (Frederick, MD)) were cultured in hMSC growth media (R&D Systems, Minneapolis, MN, USA). Adipose-derived stem cells (Passage 3-5 ...